1,233.97
13.19 (1.08%)
Previous Close | 1,220.78 |
Open | 1,214.25 |
Volume | 27,715 |
Avg. Volume (3M) | 132,664 |
Market Cap | 26,040,098,816 |
Price / Earnings (TTM) | 33.25 |
Price / Earnings (Forward) | 31.25 |
Price / Sales | 7.62 |
52 Weeks Range | |
Earnings Date | 6 Jan 2025 - 10 Jan 2025 |
Profit Margin | 21.15% |
Operating Margin (TTM) | 29.36% |
Diluted EPS (TTM) | 37.12 |
Quarterly Revenue Growth (YOY) | 1.30% |
Quarterly Earnings Growth (YOY) | 4.90% |
Current Ratio (MRQ) | 1.01 |
Operating Cash Flow (TTM) | 983.66 M |
Levered Free Cash Flow (TTM) | 773.19 M |
Return on Assets (TTM) | 20.14% |
Market Trend
Short Term | Medium Term | ||
Industry | Diagnostics & Research (US) | Bearish | Mixed |
Diagnostics & Research (Global) | Bearish | Mixed | |
Stock | Mettler-Toledo International, I | Bullish | Bullish |
AIStockmoo Score
Analyst Consensus | 3.0 |
Insider Activity | NA |
Price Volatility | 4.5 |
Technical Moving Averages | 0.0 |
Technical Oscillators | 2.0 |
Average | 2.38 |
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 39%), and food retail (around 6%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 26%, China about 19% and the rest of the world about 18%. |
|
Sector | Healthcare |
Industry | Diagnostics & Research |
Investment Style | Mid Core |
% Held by Insiders | 1.54% |
% Held by Institutions | 95.15% |
52 Weeks Range | ||
Price Target Range | ||
High | 1,450.00 (Evercore ISI Group, 17.51%) | Buy |
1,450.00 (Stifel, 17.51%) | Buy | |
Median | 1,350.00 (9.40%) | |
Low | 1,300.00 (Citigroup, 5.35%) | Hold |
Average | 1,372.00 (11.19%) | |
Total | 2 Buy, 3 Hold | |
Avg. Price @ Call | 1,248.32 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Evercore ISI Group | 02 Jan 2025 | 1,450.00 (17.51%) | Buy | 1,220.78 |
Citigroup | 11 Dec 2024 | 1,300.00 (5.35%) | Hold | 1,270.63 |
Baird | 11 Nov 2024 | 1,310.00 (6.16%) | Hold | 1,250.07 |
Stifel | 11 Nov 2024 | 1,450.00 (17.51%) | Buy | 1,250.07 |
Wells Fargo | 11 Nov 2024 | 1,350.00 (9.40%) | Hold | 1,250.07 |
No data within this time range.
Date | Type | Details |
---|---|---|
10 Jan 2025 | Announcement | Mettler-Toledo International Inc. to Host Fourth Quarter 2024 Earnings Conference Call |
23 Dec 2024 | Announcement | Telescope Innovations Presents Continued Growth in Fiscal Year 2024 |
20 Dec 2024 | Announcement | Mettler-Toledo International Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference |
07 Nov 2024 | Announcement | Mettler-Toledo International Inc. Reports Third Quarter 2024 Results |
01 Nov 2024 | Announcement | Mettler-Toledo International Inc. to Present at Upcoming Investor Conferences |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |